Balyasny Asset Management
GEN

Balyasny Asset Management’s Genesis Healthcare, Inc. GEN Stock Holding History

Balyasny Asset Management’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,225
Closed -$12K – 2461
2017
Q4 		$12K Sell
15,225
-14,705
-49% -$13.1K ﹤0.01% 2024
2017
Q3 		$35K Buy
+29,930
New +$37.7K ﹤0.01% 1825

Other funds holding GEN

CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Balyasny Asset Management's GEN Position: Q1 2018 in Review

Balyasny Asset Management sold out of Genesis Healthcare, Inc. (GEN) in Q1 2018, closing a stake of 15,225 shares — an estimated $12K sold.

Balyasny Asset Management first reported a position in GEN in Q3 2017 and held it in 2 quarters. The position peaked at $35K in Q3 2017. 67 funds tracked by Wall St. Rank hold GEN as of Q1 2018.

  • Balyasny Asset Management reported no remaining Genesis Healthcare, Inc. position as of Q1 2018 after selling out during the quarter.
  • Balyasny Asset Management sold 15,225 Genesis Healthcare, Inc. shares in Q1 2018, an estimated $12K.
  • Balyasny Asset Management first reported a position in Genesis Healthcare, Inc. in Q3 2017 and held it in 2 quarters.
  • Balyasny Asset Management's Genesis Healthcare, Inc. position peaked at $35K in Q3 2017.
  • 67 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2018.

Based on Balyasny Asset Management's 13F filing for Q1 2018, filed 15 May 2018.